Inhibitive effect of niacinamide on annulus fibrosus degeneration induced by tumor necrosis factor alpha

RB Xu,ZW Shao,XQ Xiong,X Liu,XJ Hu,P Zhou
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.02.034
2007-01-01
Abstract:Aim: To investigate the protective effect and mechanism of protection of niacinamide against annulus fibrosus (AF) degeneration that is induced by tumor necrosis factor-α (TNF-α). Methods: The experiment was carried out in the Central Laboratory and Orthopaedic Laboratory, Union Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology between October and December in 2005. Chiba's intervertebral disc (IVD) culture models were enrolled from 12 Japanese white rabbits of 4 months old and 2.5-3.0 kg weight, which were offered by the Experimental Animal Center of Tongji Medical College, Huazhong University of Science and Technology. They were randomly divided into 4 groups: control group, niacinamide group (containing 0.5 g/L niacinamide), degeneration group (10 μg/L TNF-α), and treatment group (both niacinamide and TNF-α). After 1-week of culture, AFs were collected for Safranine O staining, Glycosaminoglycan (GS) content measuring, type I and II collagen as well as cysteinyl aspartate specific protease-3 (Caspase-3) expression (immunohistochemical examination). Results: 1 AF structure of rabbit IVD: The destruction of treatment group was inhibited greatly, and the staining was better than that of degeneration group. 2 Compared with degeneration group, the uronic acid content of the treatment group was increased by 48% (t =16.93, P =0.000), and was similar with that of niacinamide group (t =0.71, P =0.657). 3 The lamellar structure and continuity of Type I and II collagen was better in treatment group than in degeneration group, and the collagen content was increased compared with control group. 4 Rate of Caspase-3 positive staining AF cells was significantly lower in treatment group than in degeneration group (10.3%, 17.9%, X2=5.081, P < 0.01). Conclusion: Niacinamide can effectively inhibit the apoptosis of Caspase-3 in AFs so as to reduce destruction caused by TNF-α.
What problem does this paper attempt to address?